Biologics Market Size, Trends, Analysis, and Outlook By Product (Monoclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cellular-based Biologics, Gene-based Biologics, Others), By Application (Cancer, Infectious Diseases, Autoimmune Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Biologics market size is poised to register 12.19% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biologics market across By Product (Monoclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cellular-based Biologics, Gene-based Biologics, Others), By Application (Cancer, Infectious Diseases, Autoimmune Diseases, Others).
The Biologics Market is witnessing significant growth and therapeutic innovation in 2024 and beyond, driven by the increasing adoption of biopharmaceuticals, monoclonal antibodies, and cell-based therapies for the treatment of cancer, autoimmune diseases, and chronic inflammatory conditions, as well as the emergence of novel biologic modalities targeting previously undruggable disease pathways and molecular targets. Biologics, also known as biological drugs or biopharmaceuticals, are large molecules derived from living organisms, such as proteins, antibodies, nucleic acids, and cellular therapies, engineered to modulate specific molecular pathways, regulate immune responses, and restore physiological homeostasis in patients with complex diseases. Key trends include the development of next-generation biologic therapies, gene editing technologies, and advanced manufacturing processes to improve biologic drug potency, stability, and delivery, as well as to enhance patient accessibility and affordability through biosimilar and biobetter development programs. Additionally, there is a growing emphasis on precision medicine approaches, biomarker-driven drug development, and patient-centered care models to optimize biologic therapy selection, dosing regimens, and treatment outcomes while minimizing adverse effects and treatment-related costs. Moreover, collaborative partnerships between biopharmaceutical companies, academic research institutions, and healthcare providers are essential for advancing biologics research, conducting clinical trials, and implementing evidence-based treatment guidelines, fostering innovation and improving patient access to safe, effective, and personalized biologic therapies for a wide range of medical conditions and unmet clinical needs.
Biologics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Biologics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Biologics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Biologics industry.
Key market trends defining the global Biologics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Biologics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Biologics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Biologics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Biologics industry
Leading Biologics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Biologics companies.
Biologics Market Study- Strategic Analysis Review
The Biologics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Biologics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Biologics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Biologics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Biologics market segments. Similarly, Strong end-user demand is encouraging Canadian Biologics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Biologics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Biologics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Biologics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Biologics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Biologics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Biologics in Asia Pacific. In particular, China, India, and South East Asian Biologics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Biologics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Biologics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Biologics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Biologics.
Biologics Market Company Profiles
The global Biologics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Amgen Inc, Bristol-Myers Squibb Company, Celltrion Healthcare Co. Ltd, Eli Lilly and Company, F. Hoffmann La-Roche Ltd, Johnson & Johnson Services Inc, Novo Nordisk A/S, Samsung Biologics, Sanofi
Recent Biologics Market Developments
The global Biologics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Biologics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
Monoclonal Antibodies
Vaccines
Recombinant Hormones/Proteins
Cellular-based Biologics
Gene-based Biologics
Others
By Application
Cancer
Infectious Diseases
Autoimmune Diseases
Others
Geographical Segmentation:
AbbVie Inc
Amgen Inc
Bristol-Myers Squibb Company
Celltrion Healthcare Co. Ltd
Eli Lilly and Company
F. Hoffmann La-Roche Ltd
Johnson & Johnson Services Inc
Novo Nordisk A/S
Samsung Biologics
Sanofi
Formats Available: Excel, PDF, and PPT
The Biologics Market is witnessing significant growth and therapeutic innovation in 2024 and beyond, driven by the increasing adoption of biopharmaceuticals, monoclonal antibodies, and cell-based therapies for the treatment of cancer, autoimmune diseases, and chronic inflammatory conditions, as well as the emergence of novel biologic modalities targeting previously undruggable disease pathways and molecular targets. Biologics, also known as biological drugs or biopharmaceuticals, are large molecules derived from living organisms, such as proteins, antibodies, nucleic acids, and cellular therapies, engineered to modulate specific molecular pathways, regulate immune responses, and restore physiological homeostasis in patients with complex diseases. Key trends include the development of next-generation biologic therapies, gene editing technologies, and advanced manufacturing processes to improve biologic drug potency, stability, and delivery, as well as to enhance patient accessibility and affordability through biosimilar and biobetter development programs. Additionally, there is a growing emphasis on precision medicine approaches, biomarker-driven drug development, and patient-centered care models to optimize biologic therapy selection, dosing regimens, and treatment outcomes while minimizing adverse effects and treatment-related costs. Moreover, collaborative partnerships between biopharmaceutical companies, academic research institutions, and healthcare providers are essential for advancing biologics research, conducting clinical trials, and implementing evidence-based treatment guidelines, fostering innovation and improving patient access to safe, effective, and personalized biologic therapies for a wide range of medical conditions and unmet clinical needs.
Biologics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Biologics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Biologics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Biologics industry.
Key market trends defining the global Biologics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Biologics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Biologics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Biologics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Biologics industry
Leading Biologics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Biologics companies.
Biologics Market Study- Strategic Analysis Review
The Biologics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Biologics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Biologics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Biologics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Biologics market segments. Similarly, Strong end-user demand is encouraging Canadian Biologics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Biologics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Biologics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Biologics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Biologics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Biologics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Biologics in Asia Pacific. In particular, China, India, and South East Asian Biologics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Biologics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Biologics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Biologics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Biologics.
Biologics Market Company Profiles
The global Biologics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Amgen Inc, Bristol-Myers Squibb Company, Celltrion Healthcare Co. Ltd, Eli Lilly and Company, F. Hoffmann La-Roche Ltd, Johnson & Johnson Services Inc, Novo Nordisk A/S, Samsung Biologics, Sanofi
Recent Biologics Market Developments
The global Biologics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Biologics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
Monoclonal Antibodies
Vaccines
Recombinant Hormones/Proteins
Cellular-based Biologics
Gene-based Biologics
Others
By Application
Cancer
Infectious Diseases
Autoimmune Diseases
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AbbVie Inc
Amgen Inc
Bristol-Myers Squibb Company
Celltrion Healthcare Co. Ltd
Eli Lilly and Company
F. Hoffmann La-Roche Ltd
Johnson & Johnson Services Inc
Novo Nordisk A/S
Samsung Biologics
Sanofi
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Biologics Market Overview and Key Findings, 2024
1.2 Biologics Market Size and Growth Outlook, 2021- 2030
1.3 Biologics Market Growth Opportunities to 2030
1.4 Key Biologics Market Trends and Challenges
1.4.1 Biologics Market Drivers and Trends
1.4.2 Biologics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Biologics Companies
2. BIOLOGICS MARKET SIZE OUTLOOK TO 2030
2.1 Biologics Market Size Outlook, USD Million, 2021- 2030
2.2 Biologics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BIOLOGICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BIOLOGICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Monoclonal Antibodies
Vaccines
Recombinant Hormones/Proteins
Cellular-based Biologics
Gene-based Biologics
Others
By Application
Cancer
Infectious Diseases
Autoimmune Diseases
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Biologics Market, 2025
5.2 Asia Pacific Biologics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Biologics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Biologics Market, 2025
5.5 Europe Biologics Market Size Outlook by Type, 2021- 2030
5.6 Europe Biologics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Biologics Market, 2025
5.8 North America Biologics Market Size Outlook by Type, 2021- 2030
5.9 North America Biologics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Biologics Market, 2025
5.11 South America Pacific Biologics Market Size Outlook by Type, 2021- 2030
5.12 South America Biologics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Biologics Market, 2025
5.14 Middle East Africa Biologics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Biologics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Biologics Market Size Outlook and Revenue Growth Forecasts
6.2 US Biologics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Biologics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Biologics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Biologics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Biologics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Biologics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Biologics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Biologics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Biologics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Biologics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Biologics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Biologics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Biologics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Biologics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Biologics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Biologics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Biologics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Biologics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Biologics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Biologics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Biologics Industry Drivers and Opportunities
7. BIOLOGICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BIOLOGICS COMPANY PROFILES
8.1 Profiles of Leading Biologics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Amgen Inc
Bristol-Myers Squibb Company
Celltrion Healthcare Co. Ltd
Eli Lilly and Company
F. Hoffmann La-Roche Ltd
Johnson & Johnson Services Inc
Novo Nordisk A/S
Samsung Biologics
Sanofi
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Biologics Market Overview and Key Findings, 2024
1.2 Biologics Market Size and Growth Outlook, 2021- 2030
1.3 Biologics Market Growth Opportunities to 2030
1.4 Key Biologics Market Trends and Challenges
1.4.1 Biologics Market Drivers and Trends
1.4.2 Biologics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Biologics Companies
2. BIOLOGICS MARKET SIZE OUTLOOK TO 2030
2.1 Biologics Market Size Outlook, USD Million, 2021- 2030
2.2 Biologics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BIOLOGICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BIOLOGICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Monoclonal Antibodies
Vaccines
Recombinant Hormones/Proteins
Cellular-based Biologics
Gene-based Biologics
Others
By Application
Cancer
Infectious Diseases
Autoimmune Diseases
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Biologics Market, 2025
5.2 Asia Pacific Biologics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Biologics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Biologics Market, 2025
5.5 Europe Biologics Market Size Outlook by Type, 2021- 2030
5.6 Europe Biologics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Biologics Market, 2025
5.8 North America Biologics Market Size Outlook by Type, 2021- 2030
5.9 North America Biologics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Biologics Market, 2025
5.11 South America Pacific Biologics Market Size Outlook by Type, 2021- 2030
5.12 South America Biologics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Biologics Market, 2025
5.14 Middle East Africa Biologics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Biologics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Biologics Market Size Outlook and Revenue Growth Forecasts
6.2 US Biologics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Biologics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Biologics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Biologics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Biologics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Biologics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Biologics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Biologics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Biologics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Biologics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Biologics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Biologics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Biologics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Biologics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Biologics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Biologics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Biologics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Biologics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Biologics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Biologics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Biologics Industry Drivers and Opportunities
7. BIOLOGICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BIOLOGICS COMPANY PROFILES
8.1 Profiles of Leading Biologics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Amgen Inc
Bristol-Myers Squibb Company
Celltrion Healthcare Co. Ltd
Eli Lilly and Company
F. Hoffmann La-Roche Ltd
Johnson & Johnson Services Inc
Novo Nordisk A/S
Samsung Biologics
Sanofi
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
